Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
Condition: Rotavirus Gastroenteritis Interventions: Drug: ROTAVAC 5D; Drug: Placebo Sponsors: University of Chile; Bharat Biotech International Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Condition: Shigellosis Interventions: Biological: Shigella sonnei 53G; Drug: Ciprofloxacin 500 mg Sponsors: University of Oxford; KEMRI-Wellcome Trust Collaborative Research Program; KEMRI United States Army Medical Research Directorate-Kenya; Walter Reed Army Institute of Research (WRAIR); Naval Medical Research Center; PATH; Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials